Even though she s tested for the coronavirus at least eight times before, 44-year-old Sister Zoliswa Gidi-Dyosi said that all her results had come back negative.
More than 230,000 healthcare workers have so far received a Johnson & Johnson coronavirus vaccine booster shot, compared to more than 496,000 who’ve received their first jab during phase 1 of the programme earlier this year.
No blood clot reports from Sisonke vaccine trial study - Sahpra Government announced earlier this week that it had put a temporary hold on the vaccine implementation study following six reported cases of rare blood clots in women who received the Johnson & Johnson vaccine in the United States. FILE: Nurse Zoliswa Gidi-Dyosi was the first person in South Africa to receive the Johnson & Johnson COVID-19 vaccine on Wednesday, 17 February 2021. Picture: Siya Duda.
4 hours ago
CAPE TOWN - The South African Health Products Regulatory Authority (Sahpra) said that there were no major safety concerns arising from data submitted by Sisonke researchers.